The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study

Feline atopic skin syndrome (FASS) describes allergic skin diseases in cats associated with sensitivity to environmental allergens. Allergen-specific immunotherapy (ASIT) aims to reduce or eliminate symptoms associated with subsequent exposure to the causative allergen. The primary outcome of this s...

Full description

Bibliographic Details
Main Authors: Kotnik Tina, Leder Matic
Format: Article
Language:English
Published: Sciendo 2023-06-01
Series:Acta Veterinaria
Subjects:
Online Access:https://doi.org/10.2478/acve-2023-0016
_version_ 1797788977655185408
author Kotnik Tina
Leder Matic
author_facet Kotnik Tina
Leder Matic
author_sort Kotnik Tina
collection DOAJ
description Feline atopic skin syndrome (FASS) describes allergic skin diseases in cats associated with sensitivity to environmental allergens. Allergen-specific immunotherapy (ASIT) aims to reduce or eliminate symptoms associated with subsequent exposure to the causative allergen. The primary outcome of this study was to determine if the quality of life (QoL) of cats and owners improved as a result of ASIT. The secondary outcome was to determine whether the QoL improved in cats treated with ASIT compared with cats treated symptomatically. Eight cats were included in the ASIT group (AG) and 6 cats in the control group (CG). Validated quality of life questionnaires were retrospectively completed by cat owners for the period before and after treatment. The QoL of cats improved significantly with ASIT. Cats were significantly less lazy, nervous, aggressive, restrained, preened less while sleeping and hid less, were less disturbed by consultations, were more playful and interactive with their environment, and had better appetites than before treatment. Owners felt significantly less physically exhausted and less emotionally distressed compared to before ASIT treatment and their expenses were significantly lower. On the contrary various symptomatic treatments did not significantly improve the quality of life of the cats or their owners in any of the terms. No serious side effects were observed with ASIT. The quality of life of animals suffering from chronic diseases is important as it determines the decisions of owners and veterinarians on the modalities of lifelong treatment. Validated questionnaires are still rarely used in veterinary practice and research.
first_indexed 2024-03-13T01:44:14Z
format Article
id doaj.art-f33f6c2ea42f401bad636e234e5c6e26
institution Directory Open Access Journal
issn 1820-7448
language English
last_indexed 2024-03-13T01:44:14Z
publishDate 2023-06-01
publisher Sciendo
record_format Article
series Acta Veterinaria
spelling doaj.art-f33f6c2ea42f401bad636e234e5c6e262023-07-03T10:20:40ZengSciendoActa Veterinaria1820-74482023-06-0173220521710.2478/acve-2023-0016The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective StudyKotnik Tina0Leder Matic1University of Ljubljana, Veterinary Faculty, Small Animal Clinic, SI-1000Ljubljana, SloveniaVeterinarski dom Domžale, SI-1230 Domžale, SloveniaFeline atopic skin syndrome (FASS) describes allergic skin diseases in cats associated with sensitivity to environmental allergens. Allergen-specific immunotherapy (ASIT) aims to reduce or eliminate symptoms associated with subsequent exposure to the causative allergen. The primary outcome of this study was to determine if the quality of life (QoL) of cats and owners improved as a result of ASIT. The secondary outcome was to determine whether the QoL improved in cats treated with ASIT compared with cats treated symptomatically. Eight cats were included in the ASIT group (AG) and 6 cats in the control group (CG). Validated quality of life questionnaires were retrospectively completed by cat owners for the period before and after treatment. The QoL of cats improved significantly with ASIT. Cats were significantly less lazy, nervous, aggressive, restrained, preened less while sleeping and hid less, were less disturbed by consultations, were more playful and interactive with their environment, and had better appetites than before treatment. Owners felt significantly less physically exhausted and less emotionally distressed compared to before ASIT treatment and their expenses were significantly lower. On the contrary various symptomatic treatments did not significantly improve the quality of life of the cats or their owners in any of the terms. No serious side effects were observed with ASIT. The quality of life of animals suffering from chronic diseases is important as it determines the decisions of owners and veterinarians on the modalities of lifelong treatment. Validated questionnaires are still rarely used in veterinary practice and research.https://doi.org/10.2478/acve-2023-0016atopiccatsimmunotherapyskin
spellingShingle Kotnik Tina
Leder Matic
The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study
Acta Veterinaria
atopic
cats
immunotherapy
skin
title The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study
title_full The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study
title_fullStr The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study
title_full_unstemmed The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study
title_short The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study
title_sort quality of life of allergic cats treated with allergen specific immunotherapy a retrospective study
topic atopic
cats
immunotherapy
skin
url https://doi.org/10.2478/acve-2023-0016
work_keys_str_mv AT kotniktina thequalityoflifeofallergiccatstreatedwithallergenspecificimmunotherapyaretrospectivestudy
AT ledermatic thequalityoflifeofallergiccatstreatedwithallergenspecificimmunotherapyaretrospectivestudy
AT kotniktina qualityoflifeofallergiccatstreatedwithallergenspecificimmunotherapyaretrospectivestudy
AT ledermatic qualityoflifeofallergiccatstreatedwithallergenspecificimmunotherapyaretrospectivestudy